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Summary Recombinant human interferon alpha inhibits growth of a human colon cancer cell line, Colo 205.
To explore the mechanisms of IFN induced growth inhibition, quiescent Colo205 cells were stimulated to
proliferate in serum-free media by defined growth factors. Addition of insulin, transferrin and selenium (ITS)
stimulated DNA synthesis, as measured by 3H-thymidine incorporation, in a dose-dependent manner. IFN-a
(at concentrations > 100 U ml-1) inhibited ITS stimulated DNA synthesis by 63%. Inhibition of cell cycle
traverse was confirmed by flow cytometric analysis. Although IFN inhibited growth of ITS-treated cells,
steady state levels of c-myc mRNA remained above levels observed in unstimulated cells. IFN inhibited DNA
synthesis only when added prior to mitogen stimulation. IFN, added 6 h after exposure of quiescent cells to
ITS, failed to inhibit cell growth. Addition of increasing concentrations of ITS failed to overcome the IFN-
induced growth inhibition. These results suggest IFN may inhibit cell growth in part by antagonizing the
action of growth factors.
In addition to their antiviral activity, IFNs inhibit growth of
both normal and transformed cells. However, the mecha-
nisms of IFN mediated growth inhibition are not fully
understood (Clemens & McMurlan, 1985). One hypothesis to
explain the antiproliferative activity of IFNs suggests that
they act, in part, as mitogen antagonists. IFN, added
sinfjltaneously with mitogens, inhibits stimulation of DNA
synthesis and cell division. For example, the administration
of IFN concomitant with serum blocks passage out of Go/
G1 of BALB/c 3T3 fibroblasts (Lin et al., 1986). When
quiescent 3T3 cells are stimulated to initiate DNA synthesis
by epidermal growth factor (EGF) and insulin, IFN potently
inhibits DNA synthesis (Taylor-Papadimtriou et al., 1981,
1985a). EGF-stimulated thymidine incorporation by human
fibroblasts is also inhibited more than 80% by human IFN
(Lin et al., 1980). Maximum inhibition of thymidine incor-
poration is observed when cells are treated with IFN prior to
onset of DNA synthesis. Tominaga and Lengyel (1984) and
Olezak and Inglot (1980) similarly observed that treatment
of quiescent BALB/c 3T3 cells with IFN inhibits cell replica-
tion induced by platelet-derived growth factor (PDGF). In a
somewhat analogous system, Heyns et al. (1985) showed
recombinant IFN inhibits smooth muscle cell growth
induced by serum or platelet-poor plasma and PDGF. B-cell
growth factor induced proliferation of hairy cell leukaemia
cells is also inhibited by IFN (Paganelli et al., 1986). These
studies suggest IFNs may control cell growth by acting as
mitogen antagonists.
Some IFNs may be classified as naturally produced
growth inhibitors. Hematopoietic cells induced to differen-
tiate produce IFN,B which slows their own growth (Resnitsky
et al., 1986). PDGF-stimulated 3T3 fibroblasts produce
IFN 18h after c-myc activation as part of a natural process
of feedback inhibition (Zullo et al., 1986). Tumour necrosis
factor (TNF) (mitogenic for human diploid fibroblasts)
induces cellular synthesis of ,B-IFN mRNA (Kohase et al.,
1986). Anti fl-IFN antibody enhances the mitogenic effect of
TNF on confluent serum-starved fibroblasts. All of the
above observations are consistent with the assumption that
the induction of IFN by growth factors is a physiological
negative feedback mechanism involved in control of cell
proliferation.
IFN inhibits the in vitro growth of both malignant cell
lines and cells derived from patient biopsies (Clemens &
McMurlan, 1985). IFN decreases clonal growth of human
colon tumour cells, isolated directly from patients, in soft
agar (Scheitauer et al., 1985). Other workers have found the
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growth of several human colon cancer cell lines is inhibited
by both naturally produced and recombinant IFNs (Denz et
al., 1985). The Colo 205 cell line, derived from a patient with
adenocarcinoma of the colon, is sensitive to the anti-
proliferative effect of IFNax (Brouty-Boye et al., 1985). IFN
profoundly affects both proliferation and tumorigenic
capacity of this cell line.
We reasoned that part of the cytostatic effect of IFN on
Colo205 cells was due to its ability to interfere with the
proliferative stimulus of serum growth factors. The present
study demonstrates that the growth of Colo 205 cells is
dependent on insulin and transferrin. We also report that
recombinant IFN;c2 inhibits proliferation of Colo205 colon
carcinoma cells and abolishes the mitogenic effect of insulin
and transferrin.
Materials and methods
Reagents
Human recombinant IFNa-2 (1.7 x 108 unitsmg-1 protein)
was a gift of Schering Corp. (Kenilworth, NJ). Insulin,
transferrin and selenium were obtained from either Sigma (St
Louis, MO) or Collaborative Research (Sudbury, MA).
Cell cultures
Colo 205 cells (CCL 222) were obtained from the American
Type Culture Collection (Rockville, MD). The cells were
cultured in RPMI 1640 medium containing 10% (v/v) foetal
bovine serum (FBS). The cells were used within 20 passages
of the original frozen stock.
Growth inhibition of Colo205 cells
Colo 205 cells were seeded at 1 x 105 cellsml-1 in 5 ml
complete media in 25 cm2 tissue culture flasks in the
presence or absence of the indicated concentrations of IFN.
The cell number was determined on the indicated days by
releasing the cells with' trypsin and counting them in a
haemocytometer. Cell viability was assessed by exclusion of
trypan blue dye.
Thymidine incorporation assays
Colo 205 cells were plated into 24 Well tissue culture dishes
at 1 x 105 cells ml- in 1 ml RPMI 1640 media with 10%
FBS. Cells became quiescent after 3 days as determined by
FACS analysis (Table I). The monolayers were washed twice
with RPMI 1640 salts and changed to RPMI 1640 media
containing 0.5% FBS in the presence or absence of IFN at
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Table I IFN-induced inhibition of cell cycle
transit
Percent of cells
Addition Gi S G2/M
None 88 10 2
IFN 85 12 3
ITS 53 42 5
ITS and IFN 78 19 2
Quiescent Colo 205 cells were serum starved,
and incubated in the presence or absence of
IFN for 48 h as described. ITS was added and
the number of cells in various phases of the cell
cycle determined 16h later by flow cytometric
analysis of propidium iodide labelled nuclei.
the indicated concentrations. After incubation at 37°C for
48 h, insulin (5Mgml- 1), transferrin (5 ugml-1) and selenium
(5 ngml- 1) (ITS) were added. Sixteen hours later, the mono-
layers were pulsed for 60min with 1 pCi of methyl3H-
thymidine [6.7 pCimmol-1, New England Nuclear (Boston,
MA)] ml-1 of medium and incorporation into acid pre-
cipitable material determined as described (Shipley et al.,
1984). Results shown are the averages of 4 wells/point.
Assay for cell cycle distribution
The relative numbers of cells in different phases of the cell
cycle were assessed by flow cytometry using propidium
iodide stained nuclei (Krishan, 1975). Cells were trypsinized
and centrifuged to yield a cell pellet. Cells (2 x106) were
resuspended in 2 ml of a hyposmotic propidium iodide
(0.5mgml-1) (Sigma) solution and stored refrigerated, and
protected from light, until flow cytometric analysis. Both the
fluorescence and narrow angle light scatter were simul-
taneously measured using a multiparameter fluorescence
activated cell sorter (FACS IV Becton-Dickinson). Incident
light at 488 nm was provided by an argon ion laser
(Model 164-5 Spectra Physics) operated at 0.3 W in the light
stabilized mode.
Detection of c-myc mRNA
Colo 205 cells, cultured in RPMI 1640 and 10% FBS, were
seeded into T75 flasks at 1 x I05 cellsml '. After incubation at
37°C for 3 days, the confluent monolayers were washed
twice with RPMI 1640 without serum and further incubated
with RPMI 1640 and 0.5% FBS with or without
1,000 Uml-1 of IFNax at 37°C. After 48 h, half the cultures
were supplemented with ITS and 2 h later, the cells were
harvested and total cytoplasmic RNA was isolated by the
guanidium thiocyanate method (Chirgwin et al., 1980). The
RNA samples were dot blotted at different concentrations
onto nitrocellulose filters. The filters were prehybridized for
48 h under agitation at 42°C in 5 x SSC-50 mM sodium
phosphate containing 50% deionized formamide, 0.2% SDS,
0.5mM EDTA, 5 x Denhardt's and denatured salmon sperm
DNA (100pgml-1). The blots were hybridized to a c-DNA
probe nick translated to 5x 107 cpmnpg-1 DNA with aX32P-
dCTP (New England Nuclear). A 1.5 kb Clal-Eco RI DNA
fragment encoding the third exon of the human c-myc gene
was used. (Della-Favera et al., 1985). Filters were hybridized
16 h at 40°C and washed at 65°C in 2 x SSC, 0.1% SDS. The
filters were autoradiographed on X-ray film at -70°C using
intensifying screens. Autoradiograms were quantitated by
densitometric scanning using a Helena densitometer.
Statistical analysis
The two tailed Student's t test was used on paired samples to
compare control to experimental groups. Data are expressed
as mean +s.d. Statistical significance was established at the
5% level.
Results
Antiproliferative effects of IFNcz2
We initially determined the effect of recombinant IFNcx2 on
proliferation of Colo205 cells in monolayer culture. Cells
were seeded in the presence or absence of IFN as described
and the total number of viable cells determined daily.
Results indicated IFNa2 decreased cell growth to 17% of
control values (Figure 1). This was due to a cytostatic, rather
than cytotoxic, effect as cell viability, judged by trypan blue
exclusion, was unchanged (data not shown).
Increasing concentrations of IFN decreased cell growth in
a dose-dependent manner. A 50% decrease in cell growth
was observed at 125 Uml-1 of IFN (Figure 2).
Effect of IFNa2 on ITS induced DNA synthesis
We reasoned part of the cytostatic effect of IFN was due to
its ability to interfere with the proliferative stimulus of serum
factors. The mitogenic activity of insulin on Colo205 cells
and its modulation by IFN were examined. A series of
preliminary experiments established the conditions for testing
the effect of human IFN on replication of quiescent Colo
cells induced to divide by exposure to ITS. On the basis of
these experiments, we chose to expose confluent cells to
0.5% serum and increasing concentrations of IFN for 48 h.
Growth was then stimulated with ITS for 16 h. Incubation of
confluent serum-starved cells with ITS for 16h stimulated
thymidine incorporation 3-5 fold. The data in Figure 3
reveal that pretreatment of cells with IFN at concentrations
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Figure 1 Inhibition of growth of Colo205 cells by IFN.
Colo 205 cells were seeded into T25 flasks as described and
cultured in RPMI 1640 media and 10% FBS in the presence or
absence of IFN (1,000 Uml -). The cells were trypsinized and
duplicate flasks counted at the indicated times. The results of
three independent experiments were averaged.
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Figure 2 Inhibition of Colo cell growth by increasing concen-
trations of IFN. Colo205 cells were seeded into T25 flasks as
described and cultured in RPMI 1640 media and 10% FBS in the
presence or absence of the indicated concentrations of IFN and
the growth of duplicate flasks was assessed 7 days later. Values
are expressed as percent ofcontrol cultures that received no IFN.
Results are the averages of two independent experiments.
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Figure 3 Effect of IFN on ITS-stimulated growth of Colo 205
cells. Quiescent Colo 205 cells were serum starved for 48 h in the
presence or absence of the indicated concentrations of IFN. The
cells were then stimulated to grow by addition of ITS (hatched
bars) at the concentrations described. Control cultures (solid
bars) did not receive ITS. 3H thymidine incorporation into DNA
of quadruplicate wells was measured 16 h later. Results are
averages of six independent experiments.
of 100 to 5,000 Uml - blocked much of the stimulation of
DNA synthesis induced by ITS. Incubation of unstimulated
cells with IFN also decreased thymidine incorporation. How-
ever, this decrease was small (10%) in comparison to the
decrease induced in the presence of ITS. Similar results were
obtained in initial experiments when cells were assayed 48 h
after ITS stimulation suggesting increases in thymidine incor-
poration were inhibited, rather than delayed, by IFN (data
not shown). Decreases in thymidine incorporation were not
due to decreases in cell number per well as equal numbers of
cells were present at the time of ITS stimulation
(1.6+0.3 x 105 for controls vs. 1.4+0.5 x 105 for IFN treated
cultures).
Flow cytometric analysis
To ascertain if results obtained by thymidine incorporation
methods accurately reflected DNA synthesis, we also esti-
mated the movement of cells through the cell cycle by flow
cytometry. The incorporation of thymidine into acid insol-
uble material has been widely used as a convenient method
of assessing the growth inhibitory effect of IFN. However,
this technique not only assesses effects on DNA synthesis,
but also may reflect alterations in thymidine transport across
the plasma membrane, phosphorylation of nucleosides by
thymidine kinase, and changes in intracellular pools (Taylor-
Papadimitriou et al., 1985b). Therefore, cells were grown to
confluence and serum starved for 48 h in the presence or
absence of IFN (1,000 Uml-1). ITS was added and cells
harvested 16 h later. Cells were stained with propidium
iodide and the numbers of cells in G1, S, or G2/M were
assessed as described. Table I shows IFN significantly
reduced the number of cells in S phase 16 h after addition of
ITS. Flow cytometry data confirmed the inhibition of cell
growth observed with thymidine incorporation assays.
Effect of aIFN on the level of c-myc mRNA
Since IFNax2 inhibited the stimulation of DNA synthesis
induced by ITS, we tested whether IFN also impaired the
increase of c-myc mRNA usually associated with cell replica-
tion. The data in Figure 4 reveal this was not the case. As
expected, quiescent control cells expressed low levels of c-
myc transcripts. Increased levels of c-myc mRNA were
observed in cells treated with ITS only. This increased level
of steady state c-myc mRNA was also observed in cells
treated with both ITS and IFN, under conditions which
inhibit cell replication. An increase in steady state c-myc
RNA levels was also observed in IFN treated cells. Area
integration of the densitometric scans of the autoradiogram
revealed approximately equal levels of c-myc mRNA were
found in ITS stimulated cells and cells receiving ITS and
IFN (Table II).
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Figure 4 Effect of IFN on the level of c-myc mRNA induced by
ITS. Confluent Colo 205 cells were placed in RPMI 1640 contain-
ing 0.5% FBS and 1,000 Uml- of IFN if so indicated for 48h
and then stimulated to grow by addition of ITS as described.
Total RNA was extracted 2h later, dot blotted in triplicate onto
nitrocellulose at the indicated concentrations, and hybridized
with a 32P-labelled cDNA probe to c-myc. Rows 1=control,
2=ITS only, 3=IFN only, 4=ITS+IFN.
Table II Changes in c-myc mRNA expression after treat-
ment with ITS and IFN
Assay condition Relative level of c-myc expression
Control
ITS
IFN
IFN+ITS
3.3
2.2
3.15
Confluent Colo 205 cells were exposed to medium con-
taining 0.5% serum (control). Interferon (IFN)
(1,000 Uml-1) were added to half the flasks for 48 h. Half
the flasks in each of the two groups were then exposed to
insulin, transferrin and selenium as described (ITS or
ITS+IFN). Total RNA was isolated 2h later. RNA (2pg)
was dot blotted onto nitrocellulose and hybridized to a
32P labelled c-myc probe. The resulting autoradiogram
was quantitated by densitometry. Area integrals of these
profiles were calculated relative to the level in control
cells.
Effect of time of addition of IFN to quiescent Colo 205 cells
To determine optimal timing of the IFN treatment, cells
were exposed to IFN either before or after addition of ITS
at the times indicated (Figure 5). The growth inhibition
observed was compared to that obtained by treating cells
with IFN for 48 h prior to addition of ITS. IFNa2, added
simultaneously with ITS (Time 0), inhibited growth only
50% as well as IFN added for the entire 48 h pretreatment
period. IFN added 6 h after addition of ITS failed to inhibit
thymidine incorporation. We also varied the length of time
of IFN pretreatment. Thymidine incorporation was not as
effectively inhibited when cells were pretreated with IFN for
only 6 h (Figure 5).
Effect of increasing concentrations of ITS on IFN
mediated growth inhibition
To determine if increasing concentrations of ITS could
overcome the IFN mediated inhibition of cell growth, quies-
cent Colo cells were stimulated to proliferate by adding
increasing concentrations of ITS in the presence or absence
of 1,000 units of IFN. The results in Figure 6 indicate that
the degree of inhibition of thymidine incorporation was
inversely related to the concentration of mitogens. The
inhibitory effect of IFN could not be overcome by increasing
the concentration of the mitogenic stimulus. Concentrations
of ITS 10 times the maximal stimulatory concentration failed
to overcome the IFN-induced inhibition of thymidine
incorporation.150 A.W. HAMBURGER et al.
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Figure 5 Effect of time of addition of IFN on inhibition of
DNA synthesis. Colo205 cells were allowed to grow to conflu-
ence and IFN added at the indicated times either prior to
exposure to ITS or at the times indicated after exposure to ITS.
Thymidine incorporation was assessed 16h after. Results repre-
sent the percent of maximal inhibition observed when cells were
exposed to IFN for 48 h prior to addition of ITS. The maximal
inhibition observed was 63+ 5%. Values are the average of three
independent experiments (4 wells/point).
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Figure 6 Effect of increasing concentrations of ITS on IFN
induced inhibition of growth. Colo205 cells were seeded at a
density of 1 x 105 cells/well and cultured as described in 24 well
plates to achieve quiescence. Cells were then incubated in serum-
free media for 48 h in the presence or absence of IFN
(1,000 IU ml-1). Cells were stimulated with increasing concent-
rations of ITS and 3H thymidine incorporation in quadruplicate
wells determined 16 h later. Values are the averages of three
independent experiments.
Discussion
We have found that pretreatment of quiescent human colon
cancer cells with IFN abolishes the mitogenic effect of
insulin and transferrin. Our results are in accord with earlier
reports indicating the administration of IFN concomitant
with serum (Lin et al., 1986), EGF and insulin (Lin et
al., 1980; Taylor-Papadimitriou et al., 1981), or PDGF
(Tominaga & Lengyel, 1984) blocks GO/G1-S passage of
human and murine fibroblasts. Similarly, growth factor
stimulated proliferation of smooth muscle cells (Heyns et al.,
1985), or leukaemic cells (Paganelli et al., 1986), is also
inhibited by concomitant administration of IFN.
Although pretreatment with IFN diminished the mitogenic
effect of ITS, the mechanism of this effect is unknown. The
requirement for a long exposure to IFN for effective growth
inhibition in our study suggests receptor interactions leading
to the antagonistic effect. Similarly, Pfeffer et al. (1987)
recently demonstrated IFN inhibited insulin-induced growth
of Daudi cells. IFN pretreatment of cells reduced binding of
insulin to low affinity receptors. Insulin binding was most
effectively decreased by a 48 h pre-exposure to IFN. Zoon et
al. (1986) demonstrated IFN-cx inhibited the EGF-stimulated
growth of MDBK cells. IFN-a reduced binding of EGF to
these cells by decreasing both receptor number and affinity.
IFN may have similarly inhibited cell proliferation in our
study by decreasing insulin binding.
Alternatively, a secondary interaction between IFN, its
receptor, and cytoskeletal elements might have occurred.
Cytoskeletal elements, particularly the microtubules, are
thought to play a role in signal transduction. IFN can
induce tubulin mRNA and interferon's antiviral action can
be inhibited by tubulin disrupting agents (Jasny et al., 1985).
It is therefore possible that continuous occupancy of the
IFN receptor by exogenous ligand resulted in stabilization of
the tubulin network, ultimately inhibiting DNA synthesis
induced by growth factors. Taylor-Papadimitriou et al.
(1985a) have found that tubulin disrupting agents such as
colchicine or nocodazole are very effective at reversing the
inhibitory effect of IFN on DNA synthesis.
As expected, exposure of quiescent cells to ITS increased
c-myc mRNA levels. Although IFN prevented ITS-
stimulated thymidine incorporation into DNA, IFN failed to
decrease c-myc RNA levels down to those observed in
unstimulated cells. Tominaga and Lengyel (1984) similarly
reported IFN pretreatment of 3T3 cells for 48 hours did not
inhibit the ability of PDGF to increase levels of c-myc
mRNA. Einat et al. (1985) found that IFN inhibited growth
of HL-60 cells, but failed to reduce steady state levels of c-
myc mRNA. In contrast, IFN-a produced a decrease of c-
myc mRNA levels and caused G1/Go arrest of Daudi
lymphoma cells. In addition we observed increased levels of
c-myc mRNA in cells treated with IFN alone. Tominaga and
Lengyel (1984) found IFN pretreatment of 3T3 cells subse-
quently exposed to PDGF, resulted in higher levels of c-myc
mRNA than in cells treated with PDGF only. In contrast to
our study, IFN alone did not increase levels of c-myc
mRNA. The mechanism of this IFN-mediated increase in c-
myc mRNA levels is not known. Tominaga and Lengyel
(1984) suggested that the increase may reflect an IFN-
mediated inhibition of labile repressor proteins that regulate
steady state levels of c-myc mRNA. It is known that IFN
differentially regulates protein synthesis. Thus, the increase
in levels of c-myc mRNA in cells treated with IFN may be a
consequence of an impairment of synthesis of these repressor
proteins. Thus, IFN blocked thymidine incorporation
induced by ITS, but did not prevent an increase in c-myc
mRNA levels. These findings suggest expression of the c-myc
oncogene may be a primary consequence of growth factor
receptor interaction, rather than a cause or consequence of
cell proliferation.
Our results indicated addition of IFN 6h after admini-
stration of insulin failed to inhibit cell growth. Lin et al.
(1986) similarly demonstrated that addition of IFN 6h after
serum stimulation of 3T3 fibroblasts failed to inhibit cell
growth. In contrast, Lin et al. (1980) earlier found that IFN
rapidly blocks increases in thymidine incorporation even
after entry of human fibroblasts into S phase.
The inhibitory effect of IFN on Colo cultures could not be
overcome by high concentrations of ITS. The addition of
supramaximal concentrations of ITS (10 times the dose
required to elicit maximal proliferation) failed to prevent the
IFN-induced inhibition of cell growth. The inhibitory effect
of IFN is probably not due to a direct competition with ITS.
IFN may affect related but not identical cellular pathways as
ITS.
In conclusion, we have demonstrated IFN inhibits growth
of a colon cancer cell line, in part, by interfering with the
ability of ITS to induce growth. Study of the IFN induced
regulation of cellular response to insulin and transferrin will
provide further insight into the mechanisms of IFN inhibi-
tion of cell growth.
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